Cytomegalovirus-specific T-cell reconstitution following letermovir prophylaxis after hematopoietic cell transplantation

Cytomegalovirus-specific T-cell reconstitution following letermovir prophylaxis after hematopoietic cell transplantation

Uloženo v:

Podrobná bibliografie
Hlavní autoři:	Danniel Zamora, Elizabeth R. Duke, Hu Xie, Bradley Edmison, Brenda Akoto, Richard Kiener, Terry Stevens-Ayers, Ralf Wagner, Marco Mielcarek, Wendy M. Leisenring, Keith R. Jerome, Joshua T. Schiffer, Greg Finak, Stephen C. De Rosa, Michael Boeckh
Médium:	Artigo
Jazyk:	angličtina
Vydáno:	2021
On-line přístup:	https://doi.org/10.1182/blood.2020009396 https://ashpublications.org/blood/article-pdf/138/1/34/1812988/bloodbld2020009396.pdf
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky

Cytomegalovirus-specific T-cell reconstitution following letermovir prophylaxis after hematopoietic cell transplantation
Autor: Zamora, Danniel, a další
Vydáno: (2021)

194. Combinatorial Polyfunctionality Analysis of Antigen-specific T-cell Subsets (COMPASS) as a Predictor for Clinically Significant CMV Infection in the Letermovir Era
Autor: Zamora, Danniel, a další
Vydáno: (2020)

Letermovir for cytomegalovirus prophylaxis
Vydáno: (2019)

Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
Autor: Francisco M. Marty, a další
Vydáno: (2017)

20. Risk Factors for Breakthrough Cytomegalovirus (CMV) Infection and De Novo Resistance in Hematopoietic Cell Transplantation (HCT) Recipients Receiving Letermovir Prophylaxis
Autor: Zamora, Danniel, a další
Vydáno: (2021)

Delayed-onset cytomegalovirus infection is frequent after discontinuing letermovir in cord blood transplant recipients
Autor: Hill, Joshua A., a další
Vydáno: (2021)

Delayed-onset cytomegalovirus infection is frequent after discontinuing letermovir in cord blood transplant recipients
Autor: Joshua A. Hill, a další
Vydáno: (2021)

Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell Transplantation
Autor: Roy F. Chemaly, a další
Vydáno: (2014)

2591. The Role of Neutralizing Antibodies (nAb) Against Cytomegalovirus (CMV) Epithelial Cell-entry in Patients with Self-limited (SL) CMV infection after Hematopoietic Cell Transplantation (HCT)
Autor: Zamora, Danniel, a další
Vydáno: (2019)

Human Cytomegalovirus-Specific T-Cell Reconstitution and Late-Onset Cytomegalovirus Infection in Hematopoietic Stem Cell Transplantation Recipients following Letermovir Prophylaxis
Autor: Elisa Gabanti, a další
Vydáno: (2022)

2648. Terminating the Troll of Transplantation: Letermovir for Cytomegalovirus Prophylaxis
Autor: Hedvat, Jason, a další
Vydáno: (2019)

Letermovir for <i>Cytomegalovirus</i> prophylaxis in pediatric hematopoietic stem cell transplantation
Autor: Teaghan T. Chen, a další
Vydáno: (2023)

Letermovir Resistance in Hematopoietic Stem Cell Transplant Recipients: The Risks Associated with Cytomegalovirus Prophylaxis
Autor: James, Scott H
Vydáno: (2020)

Refractory and Resistant Cytomegalovirus After Hematopoietic Cell Transplant in the Letermovir Primary Prophylaxis Era
Autor: Sassine, Joseph, a další
Vydáno: (2021)

Refractory and Resistant Cytomegalovirus After Hematopoietic Cell Transplant in the Letermovir Primary Prophylaxis Era
Autor: Joseph Sassine, a další
Vydáno: (2021)

Pharmacokinetics, Safety, and Efficacy of Letermovir for Cytomegalovirus Prophylaxis in Adolescent Hematopoietic Cell Transplantation Recipients
Autor: Andreas H. Groll, a další
Vydáno: (2024)

Letermovir as Cytomegalovirus Prophylaxis in a Pediatric Cohort: A Retrospective Analysis
Autor: Alexis Kuhn, a další
Vydáno: (2022)

Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients
Autor: Ajit P. Limaye, a další
Vydáno: (2023)

Cytomegalovirus Humoral Response Against Epithelial Cell Entry-Mediated Infection in the Primary Infection Setting After Hematopoietic Cell Transplantation
Autor: Zamora, Danniel, a další
Vydáno: (2020)

1102. Reconstitution of CMV-specific cell-mediated immunity during letermovir prophylaxis in hematopoietic stem cell recipients
Autor: Abidi, Maheen, a další
Vydáno: (2020)

Letermovir Resistance Analysis in a Clinical Trial of Cytomegalovirus Prophylaxis for Hematopoietic Stem Cell Transplant Recipients
Autor: Douglas, Cameron M, a další
Vydáno: (2020)

Letermovir Resistance Analysis in a Clinical Trial of Cytomegalovirus Prophylaxis for Hematopoietic Stem Cell Transplant Recipients
Autor: Cameron Douglas, a další
Vydáno: (2019)

Cytomegalovirus Prevention in Thoracic Organ Transplantation: A Single-Center Evaluation of Letermovir Prophylaxis
Autor: Saullo, Jennifer L., a další
Vydáno: (2022)

Fast breakthrough of resistant cytomegalovirus during secondary letermovir prophylaxis in a hematopoietic stem cell transplant recipient
Autor: Jung, Susanne, a další
Vydáno: (2019)

A Mortality Analysis of Letermovir Prophylaxis for Cytomegalovirus (CMV) in CMV-seropositive Recipients of Allogeneic Hematopoietic Cell Transplantation
Autor: Ljungman, Per, a další
Vydáno: (2020)

A Mortality Analysis of Letermovir Prophylaxis for Cytomegalovirus (CMV) in CMV-seropositive Recipients of Allogeneic Hematopoietic Cell Transplantation
Autor: Per Ljungman, a další
Vydáno: (2019)

Fast breakthrough of resistant cytomegalovirus during secondary letermovir prophylaxis in a hematopoietic stem cell transplant recipient
Autor: Susanne Jung, a další
Vydáno: (2019)

Letermovir for Cytomegalovirus Prevention in Patients Undergoing Hematopoietic Cell Transplantation
Autor: Daniels, Kori, a další
Vydáno: (2019)

Letermovir Prophylaxis for Cytomegalovirus Infection in Allogeneic Stem Cell Transplantation: A Real-World Experience
Autor: Martino, Massimo, a další
Vydáno: (2021)

Letermovir for the compassionate therapeutic use of cytomegalovirus infection
Autor: Schubert, Lorenz, a další
Vydáno: (2020)

Letermovir Prophylaxis and Cytomegalovirus Reactivation in Adult Hematopoietic Cell Transplant Recipients with and without Acute Graft Versus Host Disease
Autor: Wolfe, Delaney, a další
Vydáno: (2021)

Predictors of breakthrough clinically significant cytomegalovirus infection during letermovir prophylaxis in high‐risk hematopoietic cell transplant recipients
Autor: Royston, Léna, a další
Vydáno: (2021)

Cost-effectiveness analysis of the use of letermovir for the prophylaxis of cytomegalovirus in adult cytomegalovirus seropositive recipients undergoing allogenic hematopoietic stem cell transplantation in Italy
Autor: Restelli, Umberto, a další
Vydáno: (2019)

Letermovir for Prophylaxis and Pre-emptive Therapy of Cytomegalovirus Infection in Paediatric Allogeneic Haematopoietic Cell Transplant Patients
Autor: Katharina F. Körholz, a další
Vydáno: (2022)

Prospective Assessment of Cytomegalovirus Immunity in High-Risk Donor-Seropositive/Recipient-Seronegative Liver Transplant Recipients Receiving Either Preemptive Therapy or Antiviral Prophylaxis
Autor: Limaye, Ajit P, a další
Vydáno: (2019)

Effect of Preemptive Therapy vs Antiviral Prophylaxis on Cytomegalovirus Disease in Seronegative Liver Transplant Recipients With Seropositive Donors
Autor: Nina Singh, a další
Vydáno: (2020)

Letermovir Treatment of Human Cytomegalovirus Infection Antiinfective Agent
Autor: Verghese, Priya S., a další
Vydáno: (2013)

Letermovir as Salvage Therapy for Cytomegalovirus Infection in Transplant Recipients
Autor: Pakpoom Phoompoung, a další
Vydáno: (2019)

Impact of GVHD prophylaxis on CMV reactivation and disease after HLA-matched peripheral blood stem cell transplantation
Autor: Masumi Ueda, a další
Vydáno: (2023)

Letermovir prophylaxis is effective in preventing cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: single-center real-world data
Autor: Derigs, Patrick, a další
Vydáno: (2020)